Court Scraps Counterclaims Against J&J Unit
A month after upholding the validity and enforceability of a Johnson & Johnson unit's patent for the antipsychotic drug Risperdal, a New Jersey district court has thrown out a slew of...To view the full article, register now.
Already a subscriber? Click here to view full article